microdosing semaglutide for weight loss People are 'microdosing' weight-loss drugs. A GP explains what to watch out Microdosing Semaglutide: The Gentle GLP-1

Studies have found that people with type 2 diabetes are more likely to develop Alzheimers disease

Studies evaluating GLP-1 receptor agonists have consistently shown that lean body mass can account for approximately 20% to 40% of total weight reduction

Semaglutide dosing follows a carefully structured escalation protocol, and reaching the 0.75mg dose marks a significant threshold in your weight management journey

The legal requirements are clear, enforcement is active and aggressive, and the consequences of non-compliance are severe.

Taking exogenous GLP-1 medications alters how your digestive system, pancreas, and liver process nutrients